trending Market Intelligence /marketintelligence/en/news-insights/trending/lalBY0niVQLvgpcMN1Yfxg2 content esgSubNav
In This List

Vical enters research collaboration with AnGes MG

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Vical enters research collaboration with AnGes MG

Vical Inc. entered into a research collaboration agreement with AnGes MG Inc.

Under the agreement, AnGes agreed to provide funding for the program up to a specified limit, and Vical agreed to conduct certain preclinical research related to a development program targeting chronic hepatitis B.

In exchange for the payment, AnGes will receive an option to negotiate exclusive rights in Japan related to the program.

The companies also agreed to share the costs of prosecuting and maintaining intellectual property rights arising from the research program after such costs reach a specified limit.